150 related articles for article (PubMed ID: 8142259)
21. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Edström S; Cvetkovska E; Westin T; Young C
Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
[TBL] [Abstract][Full Text] [Related]
22. Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.
Bolger BS; Cooke TG; Symonds RP; MacLean AB; Stanton PD
Br J Cancer; 1993 Jul; 68(1):166-71. PubMed ID: 8318408
[TBL] [Abstract][Full Text] [Related]
23. The labelling index: a prognostic factor in head and neck carcinoma.
Chauvel P; Courdi A; Gioanni J; Vallicioni J; Santini J; Demard F
Radiother Oncol; 1989 Mar; 14(3):231-7. PubMed ID: 2710954
[TBL] [Abstract][Full Text] [Related]
24. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
[TBL] [Abstract][Full Text] [Related]
25. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
[TBL] [Abstract][Full Text] [Related]
26. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
[TBL] [Abstract][Full Text] [Related]
27. Proliferation characteristics of human colorectal carcinomas measured in vivo.
Rew DA; Wilson GD; Taylor I; Weaver PC
Br J Surg; 1991 Jan; 78(1):60-6. PubMed ID: 1998868
[TBL] [Abstract][Full Text] [Related]
28. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
Wilson GD; Dische S; Saunders MI
Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
[TBL] [Abstract][Full Text] [Related]
29. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
30. Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours.
Rew DA; Campbell ID; Taylor I; Wilson GD
Br J Surg; 1992 Apr; 79(4):335-9. PubMed ID: 1576503
[TBL] [Abstract][Full Text] [Related]
31. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine.
Erba E; Giordano M; Danova M; Mazzini G; Ubezio P; Torri V; Mangioni C; Landoni F; Bolis P; Tenti P
Ann Oncol; 1994 Sep; 5(7):627-34. PubMed ID: 7993839
[TBL] [Abstract][Full Text] [Related]
32. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
33. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance.
Michel P; Paresy M; Lepessot F; Hellot MF; Paillot B; Scotte M; Peillon C; Ducrotté P; Hemet J
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):275-80. PubMed ID: 10750646
[TBL] [Abstract][Full Text] [Related]
34. A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck.
Jones AS; Roland NJ; Caslin AW; Cooke TG; Cooke LD; Forster G
J Laryngol Otol; 1994 Oct; 108(10):859-64. PubMed ID: 7989834
[TBL] [Abstract][Full Text] [Related]
35. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
[TBL] [Abstract][Full Text] [Related]
36. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
Trerè D; Ceccarelli C; Danova M; Derenzini M
Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
[TBL] [Abstract][Full Text] [Related]
37. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
Haustermans K; Fowler JF
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
[TBL] [Abstract][Full Text] [Related]
38. Effect of radiation therapy on the potential doubling time of tumours in colorectal cancers.
Michel P; Paresy M; Lepessot F; Mauillon J; Seng S; Scotte M; Peillon C; Ducrotté P; Hemet J; Paillot B
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):309-14. PubMed ID: 10333205
[TBL] [Abstract][Full Text] [Related]
39. Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer.
Bourhis J; Wilson G; Wibault P; Janot F; Bosq J; Armand JP; Luboinski B; Malaise EP; Eschwege F
Laryngoscope; 1994 Apr; 104(4):468-72. PubMed ID: 8164487
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy.
Zackrisson B; Gustafsson H; Stenling R; Flygare P; Wilson GD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):677-83. PubMed ID: 9240632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
